 | • レポートコード：MRC2-11QY02899 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、116ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は細菌性膣炎薬のグローバル市場について調査・分析したレポートです。種類別（経口、局所）市場規模、用途別（骨盤内炎症性疾患、早産児、尿路感染症、性感染症（STD））市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別細菌性膣炎薬の競争状況、市場シェア ・世界の細菌性膣炎薬市場：種類別市場規模 2015年-2020年（経口、局所） ・世界の細菌性膣炎薬市場：種類別市場規模予測 2021年-2026年（経口、局所） ・世界の細菌性膣炎薬市場：用途別市場規模 2015年-2020年（骨盤内炎症性疾患、早産児、尿路感染症、性感染症（STD）） ・世界の細菌性膣炎薬市場：用途別市場規模予測 2021年-2026年（骨盤内炎症性疾患、早産児、尿路感染症、性感染症（STD）） ・北米の細菌性膣炎薬市場分析：米国、カナダ ・ヨーロッパの細菌性膣炎薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの細菌性膣炎薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の細菌性膣炎薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの細菌性膣炎薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Bayer、Pfizer、Sanofi、Starpharma Holdings ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Bacterial vaginosis is an imbalance of “good” and “bad” bacteria in the vagina, with there being more bad bacteria. Causes of an imbalance of bacteria can be caused by multiple sex partners and douching. Symptoms include odor, discharge, burning, and itching. Treatments for bacterial vaginosis include the use of probiotics and medication. Common drug classes include lincosamide antibiotics and nitroimidazole antibiotics.
One driver in the market is unmet demand in BV treatment market. Unmet demand in the treatment of BV has created great opportunity for the market players. There is huge unmet need in the treatment of BV, especially the recurrent form of the disease. BV is the most common vaginal infection in the women of child bearing age group. Despite being highly prevalent in nature, little has been done in the field. When left untreated, it may lead to severe infections, especially in the case of pregnant women such as preterm births. rising awareness about women’s health as one of the primary growth factors for the bacterial vaginosis drugs market. Owing to recent advancements in healthcare and the initiatives taken by the government and non-government organizations to increase the awareness about health of women, the demand for pharmaceuticals related to disorders in women will witness a significant increase in the coming years. Additionally, support from government is also a key driver.
Market Analysis and Insights: Global Bacterial Vaginosis Drugs Market
The global Bacterial Vaginosis Drugs market size is projected to reach US$ 888.1 million by 2026, from US$ 858.4 million in 2020, at a CAGR of 3.2%% during 2021-2026.
Global Bacterial Vaginosis Drugs Scope and Market Size
Bacterial Vaginosis Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Bacterial Vaginosis Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Bacterial Vaginosis Drugs market is segmented into
Oral
Topical
Segment by Application, the Bacterial Vaginosis Drugs market is segmented into
Pelvic Inflammatory Disease
Preterm Delivery of Infants
Urinary Tract Infection
Sexually Transmitted Diseases (STD)
Regional and Country-level Analysis
The Bacterial Vaginosis Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Bacterial Vaginosis Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Bacterial Vaginosis Drugs Market Share Analysis
Bacterial Vaginosis Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Bacterial Vaginosis Drugs business, the date to enter into the Bacterial Vaginosis Drugs market, Bacterial Vaginosis Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer
Pfizer
Sanofi
Starpharma Holdings
…
1 Study Coverage
1.1 Bacterial Vaginosis Drugs Product Introduction
1.2 Market Segments
1.3 Key Bacterial Vaginosis Drugs Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by Type
1.4.2 Oral
1.4.3 Topical
1.5 Market by Application
1.5.1 Global Bacterial Vaginosis Drugs Market Size Growth Rate by Application
1.5.2 Pelvic Inflammatory Disease
1.5.3 Preterm Delivery of Infants
1.5.4 Urinary Tract Infection
1.5.5 Sexually Transmitted Diseases (STD)
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Bacterial Vaginosis Drugs Market Size, Estimates and Forecasts
2.1.1 Global Bacterial Vaginosis Drugs Revenue 2015-2026
2.1.2 Global Bacterial Vaginosis Drugs Sales 2015-2026
2.2 Global Bacterial Vaginosis Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Bacterial Vaginosis Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Bacterial Vaginosis Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Bacterial Vaginosis Drugs Competitor Landscape by Players
3.1 Bacterial Vaginosis Drugs Sales by Manufacturers
3.1.1 Bacterial Vaginosis Drugs Sales by Manufacturers (2015-2020)
3.1.2 Bacterial Vaginosis Drugs Sales Market Share by Manufacturers (2015-2020)
3.2 Bacterial Vaginosis Drugs Revenue by Manufacturers
3.2.1 Bacterial Vaginosis Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Bacterial Vaginosis Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Bacterial Vaginosis Drugs Revenue in 2019
3.2.5 Global Bacterial Vaginosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Bacterial Vaginosis Drugs Price by Manufacturers
3.4 Bacterial Vaginosis Drugs Manufacturing Base Distribution, Product Types
3.4.1 Bacterial Vaginosis Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Bacterial Vaginosis Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Bacterial Vaginosis Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Bacterial Vaginosis Drugs Market Size by Type (2015-2020)
4.1.1 Global Bacterial Vaginosis Drugs Sales by Type (2015-2020)
4.1.2 Global Bacterial Vaginosis Drugs Revenue by Type (2015-2020)
4.1.3 Bacterial Vaginosis Drugs Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Bacterial Vaginosis Drugs Market Size Forecast by Type (2021-2026)
4.2.1 Global Bacterial Vaginosis Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Bacterial Vaginosis Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Bacterial Vaginosis Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Bacterial Vaginosis Drugs Market Size by Application (2015-2020)
5.1.1 Global Bacterial Vaginosis Drugs Sales by Application (2015-2020)
5.1.2 Global Bacterial Vaginosis Drugs Revenue by Application (2015-2020)
5.1.3 Bacterial Vaginosis Drugs Price by Application (2015-2020)
5.2 Bacterial Vaginosis Drugs Market Size Forecast by Application (2021-2026)
5.2.1 Global Bacterial Vaginosis Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Bacterial Vaginosis Drugs Price Forecast by Application (2021-2026)
6 North America
6.1 North America Bacterial Vaginosis Drugs by Country
6.1.1 North America Bacterial Vaginosis Drugs Sales by Country
6.1.2 North America Bacterial Vaginosis Drugs Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Bacterial Vaginosis Drugs Market Facts & Figures by Type
6.3 North America Bacterial Vaginosis Drugs Market Facts & Figures by Application
7 Europe
7.1 Europe Bacterial Vaginosis Drugs by Country
7.1.1 Europe Bacterial Vaginosis Drugs Sales by Country
7.1.2 Europe Bacterial Vaginosis Drugs Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Bacterial Vaginosis Drugs Market Facts & Figures by Type
7.3 Europe Bacterial Vaginosis Drugs Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Bacterial Vaginosis Drugs by Region
8.1.1 Asia Pacific Bacterial Vaginosis Drugs Sales by Region
8.1.2 Asia Pacific Bacterial Vaginosis Drugs Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Bacterial Vaginosis Drugs Market Facts & Figures by Type
8.3 Asia Pacific Bacterial Vaginosis Drugs Market Facts & Figures by Application
9 Latin America
9.1 Latin America Bacterial Vaginosis Drugs by Country
9.1.1 Latin America Bacterial Vaginosis Drugs Sales by Country
9.1.2 Latin America Bacterial Vaginosis Drugs Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Bacterial Vaginosis Drugs Market Facts & Figures by Type
9.3 Central & South America Bacterial Vaginosis Drugs Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Bacterial Vaginosis Drugs by Country
10.1.1 Middle East and Africa Bacterial Vaginosis Drugs Sales by Country
10.1.2 Middle East and Africa Bacterial Vaginosis Drugs Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Bacterial Vaginosis Drugs Market Facts & Figures by Type
10.3 Middle East and Africa Bacterial Vaginosis Drugs Market Facts & Figures by Application
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Bacterial Vaginosis Drugs Products Offered
11.1.5 Bayer Related Developments
11.2 Pfizer
11.2.1 Pfizer Corporation Information
11.2.2 Pfizer Description and Business Overview
11.2.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Pfizer Bacterial Vaginosis Drugs Products Offered
11.2.5 Pfizer Related Developments
11.3 Sanofi
11.3.1 Sanofi Corporation Information
11.3.2 Sanofi Description and Business Overview
11.3.3 Sanofi Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Sanofi Bacterial Vaginosis Drugs Products Offered
11.3.5 Sanofi Related Developments
11.4 Starpharma Holdings
11.4.1 Starpharma Holdings Corporation Information
11.4.2 Starpharma Holdings Description and Business Overview
11.4.3 Starpharma Holdings Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Starpharma Holdings Bacterial Vaginosis Drugs Products Offered
11.4.5 Starpharma Holdings Related Developments
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Description and Business Overview
11.1.3 Bayer Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Bayer Bacterial Vaginosis Drugs Products Offered
11.1.5 Bayer Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Bacterial Vaginosis Drugs Market Estimates and Projections by Region
12.1.1 Global Bacterial Vaginosis Drugs Sales Forecast by Regions 2021-2026
12.1.2 Global Bacterial Vaginosis Drugs Revenue Forecast by Regions 2021-2026
12.2 North America Bacterial Vaginosis Drugs Market Size Forecast (2021-2026)
12.2.1 North America: Bacterial Vaginosis Drugs Sales Forecast (2021-2026)
12.2.2 North America: Bacterial Vaginosis Drugs Revenue Forecast (2021-2026)
12.2.3 North America: Bacterial Vaginosis Drugs Market Size Forecast by Country (2021-2026)
12.3 Europe Bacterial Vaginosis Drugs Market Size Forecast (2021-2026)
12.3.1 Europe: Bacterial Vaginosis Drugs Sales Forecast (2021-2026)
12.3.2 Europe: Bacterial Vaginosis Drugs Revenue Forecast (2021-2026)
12.3.3 Europe: Bacterial Vaginosis Drugs Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Bacterial Vaginosis Drugs Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Bacterial Vaginosis Drugs Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Bacterial Vaginosis Drugs Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Bacterial Vaginosis Drugs Market Size Forecast by Region (2021-2026)
12.5 Latin America Bacterial Vaginosis Drugs Market Size Forecast (2021-2026)
12.5.1 Latin America: Bacterial Vaginosis Drugs Sales Forecast (2021-2026)
12.5.2 Latin America: Bacterial Vaginosis Drugs Revenue Forecast (2021-2026)
12.5.3 Latin America: Bacterial Vaginosis Drugs Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Bacterial Vaginosis Drugs Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Bacterial Vaginosis Drugs Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Bacterial Vaginosis Drugs Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Bacterial Vaginosis Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Bacterial Vaginosis Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Bacterial Vaginosis Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Bacterial Vaginosis Drugs Market Segments
Table 2. Ranking of Global Top Bacterial Vaginosis Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Bacterial Vaginosis Drugs Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Oral
Table 5. Major Manufacturers of Topical
Table 6. Global Bacterial Vaginosis Drugs Market Size Growth Rate by Application 2020-2026 (K MT)
Table 7. Global Bacterial Vaginosis Drugs Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 8. Global Bacterial Vaginosis Drugs Sales by Regions 2015-2020 (K MT)
Table 9. Global Bacterial Vaginosis Drugs Sales Market Share by Regions (2015-2020)
Table 10. Global Bacterial Vaginosis Drugs Revenue by Regions 2015-2020 (US$ Million)
Table 11. Global Bacterial Vaginosis Drugs Sales by Manufacturers (2015-2020) (K MT)
Table 12. Global Bacterial Vaginosis Drugs Sales Share by Manufacturers (2015-2020)
Table 13. Global Bacterial Vaginosis Drugs Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 14. Global Bacterial Vaginosis Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Bacterial Vaginosis Drugs as of 2019)
Table 15. Bacterial Vaginosis Drugs Revenue by Manufacturers (2015-2020) (US$ Million)
Table 16. Bacterial Vaginosis Drugs Revenue Share by Manufacturers (2015-2020)
Table 17. Key Manufacturers Bacterial Vaginosis Drugs Price (2015-2020) (USD/MT)
Table 18. Bacterial Vaginosis Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table 19. Manufacturers Bacterial Vaginosis Drugs Product Type
Table 20. Date of International Manufacturers Enter into Bacterial Vaginosis Drugs Market
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Global Bacterial Vaginosis Drugs Sales by Type (2015-2020) (K MT)
Table 23. Global Bacterial Vaginosis Drugs Sales Share by Type (2015-2020)
Table 24. Global Bacterial Vaginosis Drugs Revenue by Type (2015-2020) (US$ Million)
Table 25. Global Bacterial Vaginosis Drugs Revenue Share by Type (2015-2020)
Table 26. Bacterial Vaginosis Drugs Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 27. Global Bacterial Vaginosis Drugs Sales by Application (2015-2020) (K MT)
Table 28. Global Bacterial Vaginosis Drugs Sales Share by Application (2015-2020)
Table 29. North America Bacterial Vaginosis Drugs Sales by Country (2015-2020) (K MT)
Table 30. North America Bacterial Vaginosis Drugs Sales Market Share by Country (2015-2020)
Table 31. North America Bacterial Vaginosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 32. North America Bacterial Vaginosis Drugs Revenue Market Share by Country (2015-2020)
Table 33. North America Bacterial Vaginosis Drugs Sales by Type (2015-2020) (K MT)
Table 34. North America Bacterial Vaginosis Drugs Sales Market Share by Type (2015-2020)
Table 35. North America Bacterial Vaginosis Drugs Sales by Application (2015-2020) (K MT)
Table 36. North America Bacterial Vaginosis Drugs Sales Market Share by Application (2015-2020)
Table 37. Europe Bacterial Vaginosis Drugs Sales by Country (2015-2020) (K MT)
Table 38. Europe Bacterial Vaginosis Drugs Sales Market Share by Country (2015-2020)
Table 39. Europe Bacterial Vaginosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 40. Europe Bacterial Vaginosis Drugs Revenue Market Share by Country (2015-2020)
Table 41. Europe Bacterial Vaginosis Drugs Sales by Type (2015-2020) (K MT)
Table 42. Europe Bacterial Vaginosis Drugs Sales Market Share by Type (2015-2020)
Table 43. Europe Bacterial Vaginosis Drugs Sales by Application (2015-2020) (K MT)
Table 44. Europe Bacterial Vaginosis Drugs Sales Market Share by Application (2015-2020)
Table 45. Asia Pacific Bacterial Vaginosis Drugs Sales by Region (2015-2020) (K MT)
Table 46. Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Region (2015-2020)
Table 47. Asia Pacific Bacterial Vaginosis Drugs Revenue by Region (2015-2020) (US$ Million)
Table 48. Asia Pacific Bacterial Vaginosis Drugs Revenue Market Share by Region (2015-2020)
Table 49. Asia Pacific Bacterial Vaginosis Drugs Sales by Type (2015-2020) (K MT)
Table 50. Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Type (2015-2020)
Table 51. Asia Pacific Bacterial Vaginosis Drugs Sales by Application (2015-2020) (K MT)
Table 52. Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Application (2015-2020)
Table 53. Latin America Bacterial Vaginosis Drugs Sales by Country (2015-2020) (K MT)
Table 54. Latin America Bacterial Vaginosis Drugs Sales Market Share by Country (2015-2020)
Table 55. Latin Americaa Bacterial Vaginosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 56. Latin America Bacterial Vaginosis Drugs Revenue Market Share by Country (2015-2020)
Table 57. Latin America Bacterial Vaginosis Drugs Sales by Type (2015-2020) (K MT)
Table 58. Latin America Bacterial Vaginosis Drugs Sales Market Share by Type (2015-2020)
Table 59. Latin America Bacterial Vaginosis Drugs Sales by Application (2015-2020) (K MT)
Table 60. Latin America Bacterial Vaginosis Drugs Sales Market Share by Application (2015-2020)
Table 61. Middle East and Africa Bacterial Vaginosis Drugs Sales by Country (2015-2020) (K MT)
Table 62. Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Country (2015-2020)
Table 63. Middle East and Africa Bacterial Vaginosis Drugs Revenue by Country (2015-2020) (US$ Million)
Table 64. Middle East and Africa Bacterial Vaginosis Drugs Revenue Market Share by Country (2015-2020)
Table 65. Middle East and Africa Bacterial Vaginosis Drugs Sales by Type (2015-2020) (K MT)
Table 66. Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Type (2015-2020)
Table 67. Middle East and Africa Bacterial Vaginosis Drugs Sales by Application (2015-2020) (K MT)
Table 68. Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Application (2015-2020)
Table 69. Bayer Corporation Information
Table 70. Bayer Description and Major Businesses
Table 71. Bayer Bacterial Vaginosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 72. Bayer Product
Table 73. Bayer Recent Development
Table 74. Pfizer Corporation Information
Table 75. Pfizer Description and Major Businesses
Table 76. Pfizer Bacterial Vaginosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 77. Pfizer Product
Table 78. Pfizer Recent Development
Table 79. Sanofi Corporation Information
Table 80. Sanofi Description and Major Businesses
Table 81. Sanofi Bacterial Vaginosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 82. Sanofi Product
Table 83. Sanofi Recent Development
Table 84. Starpharma Holdings Corporation Information
Table 85. Starpharma Holdings Description and Major Businesses
Table 86. Starpharma Holdings Bacterial Vaginosis Drugs Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 87. Starpharma Holdings Product
Table 88. Starpharma Holdings Recent Development
Table 89. Global Bacterial Vaginosis Drugs Sales Forecast by Regions (2021-2026) (K MT)
Table 90. Global Bacterial Vaginosis Drugs Sales Market Share Forecast by Regions (2021-2026)
Table 91. Global Bacterial Vaginosis Drugs Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 92. Global Bacterial Vaginosis Drugs Revenue Market Share Forecast by Regions (2021-2026)
Table 93. North America: Bacterial Vaginosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 94. North America: Bacterial Vaginosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 95. Europe: Bacterial Vaginosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 96. Europe: Bacterial Vaginosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 97. Asia Pacific: Bacterial Vaginosis Drugs Sales Forecast by Region (2021-2026) (K MT)
Table 98. Asia Pacific: Bacterial Vaginosis Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 99. Latin America: Bacterial Vaginosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 100. Latin America: Bacterial Vaginosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 101. Middle East and Africa: Bacterial Vaginosis Drugs Sales Forecast by Country (2021-2026) (K MT)
Table 102. Middle East and Africa: Bacterial Vaginosis Drugs Revenue Forecast by Country (2021-2026) (US$ Million)
Table 103. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 104. Key Challenges
Table 105. Market Risks
Table 106. Main Points Interviewed from Key Bacterial Vaginosis Drugs Players
Table 107. Bacterial Vaginosis Drugs Customers List
Table 108. Bacterial Vaginosis Drugs Distributors List
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Bacterial Vaginosis Drugs Product Picture
Figure 2. Global Bacterial Vaginosis Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Oral Product Picture
Figure 4. Topical Product Picture
Figure 5. Global Bacterial Vaginosis Drugs Sales Market Share by Application in 2020 & 2026
Figure 6. Pelvic Inflammatory Disease
Figure 7. Preterm Delivery of Infants
Figure 8. Urinary Tract Infection
Figure 9. Sexually Transmitted Diseases (STD)
Figure 10. Bacterial Vaginosis Drugs Report Years Considered
Figure 11. Global Bacterial Vaginosis Drugs Market Size 2015-2026 (US$ Million)
Figure 12. Global Bacterial Vaginosis Drugs Sales 2015-2026 (K MT)
Figure 13. Global Bacterial Vaginosis Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 14. Global Bacterial Vaginosis Drugs Sales Market Share by Region (2015-2020)
Figure 15. Global Bacterial Vaginosis Drugs Sales Market Share by Region in 2019
Figure 16. Global Bacterial Vaginosis Drugs Revenue Market Share by Region (2015-2020)
Figure 17. Global Bacterial Vaginosis Drugs Revenue Market Share by Region in 2019
Figure 18. Global Bacterial Vaginosis Drugs Sales Share by Manufacturer in 2019
Figure 19. The Top 10 and 5 Players Market Share by Bacterial Vaginosis Drugs Revenue in 2019
Figure 20. Bacterial Vaginosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 21. Global Bacterial Vaginosis Drugs Sales Market Share by Type (2015-2020)
Figure 22. Global Bacterial Vaginosis Drugs Sales Market Share by Type in 2019
Figure 23. Global Bacterial Vaginosis Drugs Revenue Market Share by Type (2015-2020)
Figure 24. Global Bacterial Vaginosis Drugs Revenue Market Share by Type in 2019
Figure 25. Global Bacterial Vaginosis Drugs Market Share by Price Range (2015-2020)
Figure 26. Global Bacterial Vaginosis Drugs Sales Market Share by Application (2015-2020)
Figure 27. Global Bacterial Vaginosis Drugs Sales Market Share by Application in 2019
Figure 28. Global Bacterial Vaginosis Drugs Revenue Market Share by Application (2015-2020)
Figure 29. Global Bacterial Vaginosis Drugs Revenue Market Share by Application in 2019
Figure 30. North America Bacterial Vaginosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 31. North America Bacterial Vaginosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 32. North America Bacterial Vaginosis Drugs Sales Market Share by Country in 2019
Figure 33. North America Bacterial Vaginosis Drugs Revenue Market Share by Country in 2019
Figure 34. U.S. Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 35. U.S. Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Canada Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 37. Canada Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. North America Bacterial Vaginosis Drugs Market Share by Type in 2019
Figure 39. North America Bacterial Vaginosis Drugs Market Share by Application in 2019
Figure 40. Europe Bacterial Vaginosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 41. Europe Bacterial Vaginosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 42. Europe Bacterial Vaginosis Drugs Sales Market Share by Country in 2019
Figure 43. Europe Bacterial Vaginosis Drugs Revenue Market Share by Country in 2019
Figure 44. Germany Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 45. Germany Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. France Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 47. France Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. U.K. Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 49. U.K. Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Italy Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 51. Italy Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Russia Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 53. Russia Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Europe Bacterial Vaginosis Drugs Market Share by Type in 2019
Figure 55. Europe Bacterial Vaginosis Drugs Market Share by Application in 2019
Figure 56. Asia Pacific Bacterial Vaginosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 57. Asia Pacific Bacterial Vaginosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 58. Asia Pacific Bacterial Vaginosis Drugs Sales Market Share by Region in 2019
Figure 59. Asia Pacific Bacterial Vaginosis Drugs Revenue Market Share by Region in 2019
Figure 60. China Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 61. China Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Japan Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 63. Japan Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 64. South Korea Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 65. South Korea Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. India Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 67. India Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Australia Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 69. Australia Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Taiwan Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 71. Taiwan Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Indonesia Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 73. Indonesia Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Thailand Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 75. Thailand Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Malaysia Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 77. Malaysia Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Philippines Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 79. Philippines Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Vietnam Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 81. Vietnam Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Asia Pacific Bacterial Vaginosis Drugs Market Share by Type in 2019
Figure 83. Asia Pacific Bacterial Vaginosis Drugs Market Share by Application in 2019
Figure 84. Latin America Bacterial Vaginosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 85. Latin America Bacterial Vaginosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 86. Latin America Bacterial Vaginosis Drugs Sales Market Share by Country in 2019
Figure 87. Latin America Bacterial Vaginosis Drugs Revenue Market Share by Country in 2019
Figure 88. Mexico Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 89. Mexico Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 90. Brazil Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 91. Brazil Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 92. Argentina Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 93. Argentina Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Latin America Bacterial Vaginosis Drugs Market Share by Type in 2019
Figure 95. Latin America Bacterial Vaginosis Drugs Market Share by Application in 2019
Figure 96. Middle East and Africa Bacterial Vaginosis Drugs Sales Growth Rate 2015-2020 (K MT)
Figure 97. Middle East and Africa Bacterial Vaginosis Drugs Revenue Growth Rate 2015-2020 (US$ Million)
Figure 98. Middle East and Africa Bacterial Vaginosis Drugs Sales Market Share by Country in 2019
Figure 99. Middle East and Africa Bacterial Vaginosis Drugs Revenue Market Share by Country in 2019
Figure 100. Turkey Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 101. Turkey Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 102. Saudi Arabia Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 103. Saudi Arabia Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 104. U.A.E Bacterial Vaginosis Drugs Sales Growth Rate (2015-2020) (K MT)
Figure 105. U.A.E Bacterial Vaginosis Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Middle East and Africa Bacterial Vaginosis Drugs Market Share by Type in 2019
Figure 107. Middle East and Africa Bacterial Vaginosis Drugs Market Share by Application in 2019
Figure 108. North America Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 109. North America Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 110. Europe Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 111. Europe Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 112. Asia Pacific Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 113. Asia Pacific Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Latin America Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 115. Latin America Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Middle East and Africa Bacterial Vaginosis Drugs Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 117. Middle East and Africa Bacterial Vaginosis Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Porter's Five Forces Analysis
Figure 119. Channels of Distribution
Figure 120. Distributors Profiles
Figure 121. Bottom-up and Top-down Approaches for This Report
Figure 122. Data Triangulation
Figure 123. Key Executives Interviewed
膣炎迅速検査の世界市場（～2026年） Vaginosis is a defined as the changing conditions of the vagina. Bacterial vaginosis is an abnormal overgrowth of normal bacteria in the vagina and causes vaginal smelly discharge. The increasing prevalence of most common vaginal and sexually transmitted infection worldwide is expected to propel the…- 細菌性結膜炎薬の世界市場（～2026年） Conjunctivitis is an inflammation of the conjunctiva - the clear membrane that covers the outermost layer of an eye and the inner surface of eyelids. Conjunctivitis is segmented into three major categories: infective (viral and bacterial), allergic, and irritant (chemical). Bacterial conjunctivitis …
- 細菌性結膜炎治療の世界市場（～2026年） Bacterial conjunctivitis is a serious eye infection caused by several types of bacteria. The aforementioned figures clarify that it is one of the most common eye problems affecting people of all ages across the U.S. Such higher prevalence of the disease definitely prompts at increasing demand for ef…
- 細菌ワクチンの世界市場（～2026年） Bacterial vaccines contain killed or attenuated bacteria that activate the immune system. Different types of bacterial vaccines include, capsular polysaccharide vaccines, toxoid vaccines, purified protein vaccines, live attenuated bacterial vaccines, and killed bacterial vaccines. Rise in prevalence…
- 細菌性肺炎治療薬の世界市場（～2026年） Pneumonia is referred to as inflammatory, diseased condition of the lungs, which affects the alveoli of the lungs. Symptoms of pneumonia include chest pain, dry cough, trouble in breathing, and fever. Acquired pneumonia and health care-associated pneumonia are two types of pneumonia. Pneumonia affec…